CN104857107A - Fat-reducing composition preparation method and fat-reducing agent - Google Patents
Fat-reducing composition preparation method and fat-reducing agent Download PDFInfo
- Publication number
- CN104857107A CN104857107A CN201510282957.4A CN201510282957A CN104857107A CN 104857107 A CN104857107 A CN 104857107A CN 201510282957 A CN201510282957 A CN 201510282957A CN 104857107 A CN104857107 A CN 104857107A
- Authority
- CN
- China
- Prior art keywords
- component
- fat
- fat reducing
- preparation
- medicinal liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 41
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 239000003638 chemical reducing agent Substances 0.000 title claims description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 23
- 230000001954 sterilising effect Effects 0.000 claims abstract description 19
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 18
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims abstract description 18
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims abstract description 9
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 8
- 229920002125 Sokalan® Polymers 0.000 claims abstract description 8
- 229960001631 carbomer Drugs 0.000 claims abstract description 8
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical compound CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000004863 Frankincense Substances 0.000 claims abstract description 7
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims abstract description 6
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000008367 deionised water Substances 0.000 claims abstract description 6
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 6
- 229960005323 phenoxyethanol Drugs 0.000 claims abstract description 6
- 239000007788 liquid Substances 0.000 claims description 44
- 239000003814 drug Substances 0.000 claims description 39
- 230000001603 reducing effect Effects 0.000 claims description 30
- 239000000463 material Substances 0.000 claims description 14
- 239000000344 soap Substances 0.000 claims description 14
- 238000003756 stirring Methods 0.000 claims description 10
- 241000628997 Flos Species 0.000 claims description 9
- 235000013399 edible fruits Nutrition 0.000 claims description 9
- 239000010409 thin film Substances 0.000 claims description 9
- 238000009835 boiling Methods 0.000 claims description 8
- 238000004062 sedimentation Methods 0.000 claims description 8
- 241001057584 Myrrha Species 0.000 claims description 7
- 241000717739 Boswellia sacra Species 0.000 claims description 6
- 241000195474 Sargassum Species 0.000 claims description 6
- 238000005119 centrifugation Methods 0.000 claims description 5
- 238000004659 sterilization and disinfection Methods 0.000 claims description 5
- 238000002386 leaching Methods 0.000 claims description 2
- 238000000926 separation method Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 26
- 239000000126 substance Substances 0.000 abstract description 3
- 240000007311 Commiphora myrrha Species 0.000 abstract description 2
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract description 2
- 241001627228 Garcinia pedunculata Species 0.000 abstract description 2
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract description 2
- 244000179560 Prunella vulgaris Species 0.000 abstract description 2
- 210000000582 semen Anatomy 0.000 abstract description 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 241001474374 Blennius Species 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 abstract 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 abstract 1
- 235000009685 Crataegus X maligna Nutrition 0.000 abstract 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 abstract 1
- 235000009486 Crataegus bullatus Nutrition 0.000 abstract 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract 1
- 235000009682 Crataegus limnophila Nutrition 0.000 abstract 1
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 235000002313 Crataegus paludosa Nutrition 0.000 abstract 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 abstract 1
- 235000006679 Mentha X verticillata Nutrition 0.000 abstract 1
- 235000002899 Mentha suaveolens Nutrition 0.000 abstract 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 235000019441 ethanol Nutrition 0.000 abstract 1
- 235000008113 selfheal Nutrition 0.000 abstract 1
- 229940079593 drug Drugs 0.000 description 18
- 238000012360 testing method Methods 0.000 description 16
- 208000008589 Obesity Diseases 0.000 description 15
- 238000002474 experimental method Methods 0.000 description 15
- 235000020824 obesity Nutrition 0.000 description 15
- 230000003187 abdominal effect Effects 0.000 description 9
- 230000037396 body weight Effects 0.000 description 9
- 208000002193 Pain Diseases 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 210000000577 adipose tissue Anatomy 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 206010010726 Conjunctival oedema Diseases 0.000 description 3
- 241000607142 Salmonella Species 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical class CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 235000012631 food intake Nutrition 0.000 description 3
- 230000003907 kidney function Effects 0.000 description 3
- 230000003908 liver function Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000007886 mutagenicity Effects 0.000 description 3
- 231100000299 mutagenicity Toxicity 0.000 description 3
- 230000007170 pathology Effects 0.000 description 3
- 206010040872 skin infection Diseases 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 238000002562 urinalysis Methods 0.000 description 3
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 241000208838 Asteraceae Species 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 230000004962 physiological condition Effects 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- ATVJXMYDOSMEPO-UHFFFAOYSA-N 3-prop-2-enoxyprop-1-ene Chemical compound C=CCOCC=C ATVJXMYDOSMEPO-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 241001608538 Boswellia Species 0.000 description 1
- 235000018062 Boswellia Nutrition 0.000 description 1
- 244000080208 Canella winterana Species 0.000 description 1
- 235000008499 Canella winterana Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241001092040 Crataegus Species 0.000 description 1
- 235000017159 Crataegus pinnatifida Nutrition 0.000 description 1
- 241000657480 Crataegus pinnatifida Species 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 244000283207 Indigofera tinctoria Species 0.000 description 1
- 244000303199 Lamium album Species 0.000 description 1
- 235000009199 Lamium album Nutrition 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 201000002451 Overnutrition Diseases 0.000 description 1
- 241001529246 Platymiscium Species 0.000 description 1
- 235000010674 Prunella vulgaris Nutrition 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241000304447 Sempervivum tectorum Species 0.000 description 1
- 241000220261 Sinapis Species 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 229940086737 allyl sucrose Drugs 0.000 description 1
- 230000000578 anorexic effect Effects 0.000 description 1
- 230000000489 anti-atherogenic effect Effects 0.000 description 1
- 230000003579 anti-obesity Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 235000021268 hot food Nutrition 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 235000020823 overnutrition Nutrition 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 229940059574 pentaerithrityl Drugs 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a preparation method of a fat-reducing composition. The preparation method comprises the steps of preparing a first component and a second component, wherein the first component comprises the following substances in percentage by weight accounting for the total weight of the first component and the second component: 8% to 10% of red flower, 15% to 30% of myrrh, 4% to 6% of radix angelicae pubescentis, 3% to 5% of selfheal, 3% to 5% of hawthorn, 5% to 8% of frankincense, 5% to 7% of garcinia pedunculata, 2% to 3% of semen brassicae, 3% to 4% of seaweed and 2% to 5% of mint, and the second component comprises the following substances in percentage by weight accounting for the total weight of the first component and the second component: 1% to 2% of azone, 0.2% to 3% of borneol, 4% to 6% of 1,3-butanediol, 1% to 3% of glycerol, 0.1% to 0.5% of Carbomer, 0.1% to 0.5% of sodium hydroxide, 2% to 5% of ethyl alcohol, 0.2% to 0.8% of phenoxyethanol and the balance of deionized water; then mixing the first component with the second component uniformly after decocting, concentrating, separating and sterilizing the first component. The fat-reducing composition obtained by the preparation method has an obvious weight-reducing effect.
Description
Technical field
The present invention relates to a kind of compositions with fat reducing function, particularly relate to the preparation method of said composition.
Background technology
Simple Obesity refers to the obesity caused primarily of inherited genetic factors and overnutrition, Simple Obesity is modal one in all kinds of obesity, account for about 95% of obese people, the people's total body fat distribution suffering from Simple Obesity is more even, there is no endocrine regulation phenomenon, also without dysbolismus disease, often there is fat medical history in its family.
At present, Simple Obesity is a social problem of the highly developed country of modern economy.At some national obesity sickness rate up to 20 ~ 30%.China is due to social stability, and people's living standard improves, and dietary structure and custom are reasonable not in addition, and Simple Obesity sickness rate is also in rising trend.According to China in recent years, neonate accounted for 70%, and child 4 ~ 9.5%, adolescence 21%, the manhood 18 ~ 32%, and the geratic period reaches 28% and all suffers from obesity, but its effect of existing diet products is often obvious not.
Summary of the invention
Technical problem to be solved by this invention is to provide a kind ofly to be had the fat reducing compositions of remarkable fat-reducing effect and provides a kind of fitness reducing agent using this fat reducing compositions to prepare.
For solving the problems of the technologies described above, the present invention adopts following technical scheme:
A preparation method for fat reducing compositions, comprises the steps:
1) configure the first component and second component, the percentage ratio that each material wherein forming the first component accounts for first, second component weight is: Flos Carthami 8-10%; Myrrha 15-30%; Radix Angelicae Pubescentis 4-6%; Spica Prunellae 3-5%; Fructus Crataegi 3-5%; Olibanum 5-8%; Large fruit Resina garciniae 5-7%; Semen Sinapis Albae 2-3%; Sargassum 3-4%; Herba Menthae 2-5%; The percentage ratio that each material of composition second component accounts for first, second component weight is: azone 1-2%; Borneolum Syntheticum 0.2-3%; 1.3 butanediol 4-6%; Glycerol 1-3%; Carbomer 0.1-0.5%; Sodium hydroxide 0.1-0.5%; Ethanol 1-5%; Phenoxyethanol 0.2-0.8%; Surplus is deionized water;
2) the first component is decocted with water, get its medicinal liquid, for subsequent use after concentrated, separation, sterilizing;
3) by second component mix homogeneously, and the first component is added second component and to stir obtained fat reducing compositions.
In formula of the present invention:
Flos Carthami, Classification system: Carthamustinctorius L., another name: red indigo plant flower, thorn Flos Carthami, Compositae, Flos Carthami platymiscium, have blood circulation promoting and blood stasis dispelling, and wet dissipation goes the effect swollen.
Myrrha, has another name called myrrh, cures mainly breast abdomen stasis of blood pain, dysmenorrhea, amenorrhea, lump in the abdomen, traumatic injury, carbuncle skin infection, acute appendicitis, conjunctival congestion and swelling pain, has the effect such as promoting blood circulation and stopping pain, detumescence and promoting granulation.
Radix Angelicae Pubescentis, another name Sempervivum tectorum, solely cunning, archangel, has expelling wind and removing dampness, arthralgia aggravated by cold analgesic efficacy.
Spica Prunellae, formal name used at school: Prunella vulgaris L, another name: wheat head Spica Prunellae, can control conjunctival congestion and swelling pain, headache etc., clearing away heat-fire, improving eyesight, mass dissipating and swelling eliminating.
Fructus Crataegi, (Crataeguspinnatifida Bunge), to have another name called in mountain fruit, Rosaceae Crataegus, has aid digestion, blood fat reducing, antiatherogenic effect.
Olibanum, Boswellia, has blood-activating and qi-promoting pain relieving, effect of detumescence and promoting granulation.Be usually used in treating obstruction of qi in the chest and cardialgia, gastralgia, dysmenorrhea amenorrhea, postpartum stagnation, lump in the abdomen is suffered from abdominal pain, rheumatic arthralgia, the contracture of muscle arteries and veins, traumatic injury, carbuncle skin infection etc.
Large fruit Resina garciniae (Garciniapedunculata Roxb.), has another name called weight reducing fruit, fat-reducing fruit, has weight reducing, strengthening the spleen to promote digestion, the effects such as loosening bowel to relieve constipation, relieving sore throat and diminishing swelling, extra-nutrition, cancer-resisting.
Semen Sinapis Albae, another name hot food, Latin literary fame Semen sinapis. has warming the lung eliminating phlegm promoting the circulation of QI, resolving mass and removing the obstruction of the collateral analgesic efficacy.
Sargassum nature and flavor are salty-cold, have effect of heat clearing away, hard masses softening and resolving.
Herba Menthae is pungent cool property sweating antipyretic medicine, the disease such as be usually used in treatment influenza, headache, conjunctival congestion, fever of the body, throat, dental bed swell and ache.
Azone, molecular formula C18H35NO, can be used as penetrating agent,
Borneolum Syntheticum, has another name called Fructus Citri tangerinae sheet, is through steam distillation and recrystallization and obtaining by Compositae Herba Blumeae Balsamiferae stem and leaf or canella Borneolum Syntheticum Camphor tree branch and leaf.Can be used for treatment excess syndrome of stroke coma, conjunctival congestion and swelling pain, sore throat aphtha, to swell and ache for skin infection, do not hold back after bursting.
Carbomer, English name Carbomer is the high molecular polymer of acrylic acid bonding allyl sucrose or tetramethylolmethane allyl ether.
The main pharmacological of this formula is the activity of reconditioner body fat and metabolic enzyme, promotes that body fat is decomposed, makes body be issued to the object of fat-reducing at normal physiological condition.
Preferably, step 2) mass ratio of the first component and water is 1:4-6, decocts 1 to 3 time, merges each medicinal liquid decocted.
Preferably, decoct 3 times to the first component, the water yield of wherein first time decoction is 6 times of the first component, and the water yield of second and third decoction is 4 times.More specifically, before first time decocts, invade bubble 4-6 hour, decoct boiling and continue 30 minutes.
Preferably, the present invention first component crosses 60 mesh sieves.
Preferably, step 2) adopt thin film concentration by concentration of liquid medicine to 0.5-0.9g/ml.Concrete, add the ethanol with medicinal liquid identical weight in concentration of liquid medicine forward direction medicinal liquid, through its medicinal liquid of leaching after sedimentation.
Step 2 of the present invention) adopt centrifugalize, rotating speed is 3000 revs/min, and centrifugation time is 30 minutes.
Step 2 of the present invention) sterilising temp is 105 DEG C, sterilization time is 30 minutes.
Present invention also offers a kind of fitness reducing agent with fat reducing effect, be made up of above-mentioned gained fat reducing compositions and Transparent soap base, the mass ratio of wherein fat reducing compositions and Transparent soap base is 20:80.
The present invention takes full advantage of the advantageous natural resources of Chinese medicinal materials of China, and from over one hundred kind of Chinese herbal medicine, filter out the ten multi-flavor Chinese medicines such as Flos Carthami, Myrrha, Radix Angelicae Pubescentis, Fructus Crataegi, the extraction process through strict scientific composition and uniqueness extracts fat reducing compositions.Due to this effective ingredient and the soap class as carrier, be natural materials completely, transdermal stimulation is tested, and does not produce any irritative response to human body skin.
Confirmed by modern medical research methods, the main pharmacological of this formula is the activity of reconditioner body fat and metabolic enzyme, promote that body fat is decomposed, body is made to be issued to the object of fat-reducing at normal physiological condition, this anti-obesity mechanism than using appetite inhibiting class medicine, lead let out class medicine, hormone medicine fat-reducing is more conducive to health, achieve fat-reducing and do not force the beneficial effect of going on a diet, not subtracting muscle power, not causing metabolism disorder.
Detailed description of the invention
Below by embodiment, the present invention is specifically described further.Simple the substituting of design philosophy of the present invention or allied substances belongs to protection scope of the present invention.If following used experimental technique is without specified otherwise, be the method for the existing routine of the art, the batching used or material, if no special instructions, be by the available batching of commercial sources or material.
Embodiment 1
Fitness reducing agent of the present invention is prepared by following steps:
1) configure the first component and second component, the percentage ratio that each material wherein forming the first component accounts for first, second component weight is: Flos Carthami 7%; Myrrha 20%; Radix Angelicae Pubescentis 6%; Spica Prunellae 5%; Fructus Crataegi 4%; Olibanum 5%; Large fruit Resina garciniae 7%; Semen Sinapis Albae 3%; Sargassum 4%; Herba Menthae 5%;
The percentage ratio that each material of composition second component accounts for first, second component weight is: azone 2%; Borneolum Syntheticum 0.2%; 1.3 butanediols 4%; Glycerol 3%; Carbomer 0.1% (production of Hubei Kang Baotai fine chemistry industry company); Sodium hydroxide 0.1%; Ethanol 2%; Phenoxyethanol 0.2%; Surplus is deionized water;
2) the first component is proceeded as follows:
Pretreatment
The Chinese medicine of the first component is prepared in proportion, crosses 60 mesh sieves, remove earth;
Decoct
The Chinese medicine of the first component is put into storage tank, soaks 4-6 hours, the mass ratio of the first component drug quality and water is 1:6, then decocts to boiling at ambient pressure, and keeps boiling 30 minutes, and last vertical centrifugal goes out the medicinal liquid of first time decoction.
After taking out medicinal liquid, the water adding the first component drug quality 4 times again in medicine carries out second time and decocts, centrifugal go out second time medicinal liquid, equally, the water adding the first component drug quality 4 times again in medicine carries out third time decoction, centrifugal go out third time medicinal liquid, by above three times decoct medicinal liquid combine.
Concentrate and precipitate with ethanol
By above-mentioned medicine liquid thin film concentration traditionally, (thin film concentration refers to a kind of concentrating under reduced pressure mode of carrying out with membrane evaporator, prior art, the present invention is not described in detail) mode is concentrated into 0.5-0.6g crude drug/ml, and after taking out, normal pressure is concentrated into 0.9g crude drug/ml; Cooling sedimentation, places 1 hour by medicinal liquid room temperature, until equilibrium at room temperature; Add the ethanol with medicinal liquid 1:1, stir evenly rear sedimentation 1 hour, filtering precipitate is to clear liquid, and thin film concentration is to 0.9g crude drug/ml;
Be separated
By the medicinal liquid centrifugalize after concentrated, centrifugal rotational speed is 3000 revs/min, and centrifugation time is 30 minutes; Incline and supernatant, load sterilizing in sterilizing bottle, sterilising temp is 105 DEG C, and sterilization time is 30 minutes.
3) second component is fully dissolved, mix homogeneously, and the first component is added second component and to stir obtained fat reducing compositions.
4) by step 3) gained fat reducing compositions pour into Transparent soap base (Ba Sha cosmetics of everyday use company limited of Shenzhen produce, model is 1008) in, stir, pour into fat-reducing fancy soap, the mass ratio of fat reducing compositions and Transparent soap base is 20:80.
The using method of the present embodiment gained fat-reducing fancy soap: use the same wiping health of general fancy soap at shower time image.
Through toxotest, rat is divided three dosage groups oral 4 months, to the discovery all without exception of its body weight, food-intake, liver function, renal function, blood, routine urinalysis and each tissue pathology checking.
Salmonella reversion test and CHL cell tests system results show all not present mutagenicity.
Test 1 fat-reducing effect
This experiment carries out questionnaire survey for simple obesity patient, in the patient using embodiment 1 gained fitness reducing agent, random choose 100 uses the user of the present embodiment fat-reducing soap surrounding to investigate for more than 16 years old, statistical result is as shown in table 1, fat-reducing effect is divided into Three Estate by this experiment, it is effective, effective respectively and minor effect, as can be seen from Table 1, the present embodiment fitness reducing agent all has remarkable result on the fat-reducing effect of body weight, abdominal circumference and hip circumference, especially can obviously reduce abdominal circumference size.
Table 1 experimenter fat-reducing effect statistical table
Experiment 2
This experiment carries out questionnaire survey for simple obesity patient, in the patient using embodiment 1 gained fitness reducing agent, random choose 20 uses the user of surrounding to investigate for 8 ~ 14 years old, statistical result is as shown in table 2 to table 4, result shows, the present embodiment fitness reducing agent has significant fat-reducing effect equally to teenager.
The test result of table 2 pair teenager body weight
The test result of table 3 pair teenager abdominal circumference
The test result of table 4 pair teenager hip circumference
Embodiment 2
Fitness reducing agent of the present invention is prepared by following steps:
1) configure the first component and second component, the percentage ratio that each material wherein forming the first component accounts for first, second component weight is: Flos Carthami 10%; Myrrha 30%; Radix Angelicae Pubescentis 6%; Spica Prunellae 5%; Fructus Crataegi 5%; Olibanum 5%; Large fruit Resina garciniae 5%; Semen Sinapis Albae 2%; Sargassum 3%; Herba Menthae 3%;
The percentage ratio that each material of composition second component accounts for first, second component weight is: azone 1%; Borneolum Syntheticum 3%; 1.3 butanediols 6%; Glycerol 1%; Carbomer 0.5%; Sodium hydroxide 0.5%; Ethanol 5%; Phenoxyethanol 0.8%; Surplus is deionized water;
2) the first component is proceeded as follows:
Pretreatment
The Chinese medicine of the first component is prepared in proportion, crosses 60 mesh sieves, remove earth;
Decoct
The Chinese medicine of the first component is put into storage tank, soaks 4-6 hours, the mass ratio of the first component drug quality and water is 1:6, then decocts to boiling at ambient pressure, and keeps boiling 30 minutes, and last vertical centrifugal goes out the medicinal liquid of first time decoction.
After taking out medicinal liquid, the water adding the first component drug quality 4 times again in medicine carries out second time and decocts, centrifugal go out second time medicinal liquid, equally, the water adding the first component drug quality 4 times again in medicine carries out third time decoction, centrifugal go out third time medicinal liquid, by above three times decoct medicinal liquid combine.
Concentrated
By above-mentioned medicinal liquid thin film concentration to 0.5-0.6g crude drug/ml, after taking out, normal pressure is concentrated into 0.9g crude drug/ml; Cooling sedimentation, places 1 hour by medicinal liquid room temperature, until equilibrium at room temperature; Add the ethanol with medicinal liquid 1:1, stir evenly rear sedimentation 1 hour, filtering precipitate is to clear liquid, and thin film concentration is to 0.9g crude drug/ml;
Be separated
By the medicinal liquid centrifugalize after concentrated, centrifugal rotational speed is 3000 revs/min, and centrifugation time is 30 minutes; Incline and supernatant, load sterilizing in sterilizing bottle, sterilising temp is 105 DEG C, and sterilization time is 30 minutes.
3) by second component mix homogeneously, and the first component is added second component and to stir obtained fitness reducing agent.
The present embodiment anoretic is actually a kind of fat-reducing ointment frost, can spread upon on skin and use by Direct Uniform.
Through toxotest, rat is divided three dosage groups oral 4 months, to the discovery all without exception of its body weight, food-intake, liver function, renal function, blood, routine urinalysis and each tissue pathology checking.
Salmonella reversion test and CHL cell tests system results show all not present mutagenicity.
Experiment 3
This experiment carries out questionnaire survey for simple obesity patient, in the patient using embodiment 1 gained fitness reducing agent, random choose 100 uses the user of surrounding to investigate for more than 16 years old, statistical result is as shown in table 5, fat-reducing effect is divided into Three Estate by this experiment, is effective, effective respectively and minor effect.As can be seen from Table 5, the present embodiment fitness reducing agent all has remarkable result on the fat-reducing effect of body weight, abdominal circumference and hip circumference, especially can obviously reduce abdominal circumference size.
Table 5 experimenter fat-reducing effect statistical table
Experiment 4
This experiment carries out questionnaire survey for simple obesity patient, in the patient using embodiment 1 gained fitness reducing agent, random choose 20 uses the user of surrounding to investigate for 8 ~ 14 years old, statistical result is as shown in table 6 to table 8, result shows, the present embodiment fitness reducing agent has significant fat-reducing effect equally to teenager.
The test result of table 6 pair teenager body weight
The test result of table 7 pair teenager abdominal circumference
The test result of table 8 pair teenager hip circumference
Embodiment 3
Fitness reducing agent of the present invention is prepared by following steps:
1) configure the first component and second component, the percentage ratio that each material wherein forming the first component accounts for first, second component weight is: Flos Carthami 8%; Myrrha 15%; Radix Angelicae Pubescentis 4%; Spica Prunellae 3%; Fructus Crataegi 3%; Olibanum 8%; Large fruit Resina garciniae 5%; Semen Sinapis Albae 2%; Sargassum 3%; Herba Menthae 2%;
The percentage ratio that each material of composition second component accounts for first, second component weight is: azone 1%; Borneolum Syntheticum 3%; 1.3 butanediols 6%; Glycerol 1%; Carbomer 0.5%; Sodium hydroxide 0.5%; Ethanol 5%; Phenoxyethanol 0.8%; Surplus is deionized water;
2) the first component is proceeded as follows:
Pretreatment
The Chinese medicine of the first component is prepared in proportion, crosses 60 mesh sieves, remove earth;
Decoct
The Chinese medicine of the first component is put into storage tank, soaks 4-6 hours, the mass ratio of the first component drug quality and water is 1:6, then decocts to boiling at ambient pressure, and keeps boiling 30 minutes, and last vertical centrifugal goes out the medicinal liquid of first time decoction.
After taking out medicinal liquid, the water adding the first component drug quality 4 times again in medicine carries out second time and decocts, centrifugal go out second time medicinal liquid, equally, the water adding the first component drug quality 4 times again in medicine carries out third time decoction, centrifugal go out third time medicinal liquid, by above three times decoct medicinal liquid combine.
Concentrated
By above-mentioned medicinal liquid thin film concentration to 0.5-0.6g crude drug/ml, after taking out, normal pressure is concentrated into 0.9g crude drug/ml; Cooling sedimentation, places 1 hour by medicinal liquid room temperature, until equilibrium at room temperature; Add the ethanol with medicinal liquid 1:1, stir evenly rear sedimentation 1 hour, filtering precipitate is to clear liquid, and thin film concentration is to 0.9g crude drug/ml;
Be separated
By the medicinal liquid centrifugalize after concentrated, centrifugal rotational speed is 3000 revs/min, and centrifugation time is 30 minutes; Incline and supernatant, load sterilizing in sterilizing bottle, sterilising temp is 105 DEG C, and sterilization time is 30 minutes.
3) by second component mix homogeneously, and the first component is added second component and to stir obtained fitness reducing agent.
4) by step 3) gained fat reducing compositions pours in Transparent soap base, and stir, pour into fat-reducing fancy soap, the mass ratio of fat reducing compositions and Transparent soap base is 5:95.
Through toxotest, rat is divided three dosage groups oral 4 months, to the discovery all without exception of its body weight, food-intake, liver function, renal function, blood, routine urinalysis and each tissue pathology checking.
Salmonella reversion test and CHL cell tests system results show all not present mutagenicity.
Experiment 5
This experiment carries out questionnaire survey for simple obesity patient, in the patient using embodiment 1 gained fitness reducing agent, random choose 100 uses the user of surrounding to investigate for more than 16 years old, statistical result is as shown in table 9, fat-reducing effect is divided into Three Estate by this experiment, is effective, effective respectively and minor effect.As can be seen from Table 9, the present embodiment fitness reducing agent all has remarkable result on the fat-reducing effect of body weight, abdominal circumference and hip circumference, especially can obviously reduce abdominal circumference size.
Table 9 experimenter fat-reducing effect statistical table
Experiment 6
This experiment carries out questionnaire survey for simple obesity patient, in the patient using embodiment 1 gained fitness reducing agent, random choose 20 uses the user of surrounding to investigate for 8 ~ 14 years old, statistical result is as shown in table 10 to table 12, result shows, the present embodiment fitness reducing agent has significant fat-reducing effect equally to teenager.
The test result of table 10 pair teenager body weight
The test result of table 11 pair teenager abdominal circumference
The test result of table 12 pair teenager hip circumference
Claims (10)
1. a preparation method for fat reducing compositions, comprises the steps:
1) configure the first component and second component, the percentage ratio that each material wherein forming the first component accounts for first, second component weight is: Flos Carthami 8-10%; Myrrha 15-30%; Radix Angelicae Pubescentis 4-6%; Spica Prunellae 3-5%; Fructus Crataegi 3-5%; Olibanum 5-8%; Large fruit Resina garciniae 5-7%; Semen Sinapis Albae 2-3%; Sargassum 3-4%; Herba Menthae 2-5%; The percentage ratio that each material of composition second component accounts for first, second component weight is: azone 1-2%; Borneolum Syntheticum 0.2-3%; 1.3 butanediol 4-6%; Glycerol 1-3%; Carbomer 0.1-0.5%; Sodium hydroxide 0.1-0.5%; Ethanol 2-5%; Phenoxyethanol 0.2-0.8%; Surplus is deionized water;
2) the first component is decocted with water, get its medicinal liquid, for subsequent use after concentrated, separation, sterilizing;
3) by second component mix homogeneously, and the first component is added second component and to stir obtained fat reducing compositions.
2. fat reducing preparation method of composition according to claim 1, is characterized in that, step 2) mass ratio of the first component and water is 1:4-6, decocts 1 to 3 time, merges each medicinal liquid decocted.
3. fat reducing preparation method of composition according to claim 2, is characterized in that, decocts 3 times to the first component, and the water yield of wherein first time decoction is 6 times of the first component, and the water yield of second and third decoction is 4 times.
4. fat reducing preparation method of composition according to claim 3, is characterized in that, invades bubble 4-6 hour before first time decocts, and decocts boiling and continues 30 minutes.
5. fat reducing preparation method of composition according to claim 4, is characterized in that, the first component crosses 60 mesh sieves.
6., according to the arbitrary described fat reducing preparation method of composition of claim 1 to 5, it is characterized in that, step 2) adopt thin film concentration by concentration of liquid medicine to 0.5-0.9g/ml.
7. fat reducing preparation method of composition according to claim 6, is characterized in that, adds the ethanol with medicinal liquid identical weight in concentration of liquid medicine forward direction medicinal liquid, through its medicinal liquid of leaching after sedimentation.
8. fat reducing preparation method of composition according to claim 7, is characterized in that, step 2) adopt centrifugalize, rotating speed is 3000 revs/min, and centrifugation time is 30 minutes.
9. fat reducing preparation method of composition according to claim 6, is characterized in that, step 2) sterilising temp is 105 DEG C, sterilization time is 30 minutes.
10. a fitness reducing agent, is made up of claim 1 to 9 gained fat reducing compositions and Transparent soap base, and the mass ratio of wherein fat reducing compositions and Transparent soap base is 5 ~ 20:80 ~ 95.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510282957.4A CN104857107B (en) | 2015-05-28 | 2015-05-28 | A kind of fat reducing preparation method of composition and fitness reducing agent |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510282957.4A CN104857107B (en) | 2015-05-28 | 2015-05-28 | A kind of fat reducing preparation method of composition and fitness reducing agent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104857107A true CN104857107A (en) | 2015-08-26 |
| CN104857107B CN104857107B (en) | 2018-04-10 |
Family
ID=53903574
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510282957.4A Expired - Fee Related CN104857107B (en) | 2015-05-28 | 2015-05-28 | A kind of fat reducing preparation method of composition and fitness reducing agent |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104857107B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105231199A (en) * | 2015-09-16 | 2016-01-13 | 安徽阜南常晖食品有限公司 | Fat eliminating and health preserving sweet orange drink |
| CN105265948A (en) * | 2015-09-14 | 2016-01-27 | 安徽阜南常晖食品有限公司 | Immunity enhancing jelly coconut juice |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1824194A (en) * | 2005-12-28 | 2006-08-30 | 王燕红 | Pure Chinese medicine external use body fat reducing medicine |
-
2015
- 2015-05-28 CN CN201510282957.4A patent/CN104857107B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1824194A (en) * | 2005-12-28 | 2006-08-30 | 王燕红 | Pure Chinese medicine external use body fat reducing medicine |
Non-Patent Citations (2)
| Title |
|---|
| 余孟学: "《疑难杂病临证效验方》", 30 April 2012 * |
| 王会宁等: "复方芳香植物提取物对营养型肥胖大鼠的减肥作用", 《中国实验方剂学杂志》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105265948A (en) * | 2015-09-14 | 2016-01-27 | 安徽阜南常晖食品有限公司 | Immunity enhancing jelly coconut juice |
| CN105231199A (en) * | 2015-09-16 | 2016-01-13 | 安徽阜南常晖食品有限公司 | Fat eliminating and health preserving sweet orange drink |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104857107B (en) | 2018-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104826016B (en) | A kind of pharmaceutical composition and its preparation method and application for treating the proliferation of mammary gland | |
| CN104857107A (en) | Fat-reducing composition preparation method and fat-reducing agent | |
| CN101023992B (en) | Medicine for treating mammary gland hyperplasia | |
| WO1999025368A1 (en) | A medicine for treating algomenorrhea and the method of preparation thereof | |
| CN103751547B (en) | Chinese medicine composition of a kind of blood fat reducing and preparation method thereof | |
| CN100409869C (en) | Externally-applied medicinal liquid for treating dermatosis | |
| CN105250427A (en) | Pharmaceutical composition for treating heart diseases | |
| CN101757444A (en) | Orally administrated medicine for Chinese traditional treatment of thyroid nodule | |
| CN104107264A (en) | Traditional Chinese medicine agent for treating infantile constipation and preparation method and application of traditional Chinese medicine agent | |
| CN112826904A (en) | Medicine for quickly treating hyperplasia of mammary glands | |
| CN103705857B (en) | For preventing the Chinese medicine composition of oral cavity radiomucitis | |
| CN102406790A (en) | Traditional Chinese medicine capsule for treating hyperplasia of mammary glands and preparation method thereof | |
| CN104013815A (en) | Traditional Chinese medicine for treating recurrent oral ulcer due to deficiency of yin and excess of heat and preparation method of traditional Chinese medicine | |
| CN104840806B (en) | Chinese medicinal preparation with anti-rheumatoid effect and production method thereof | |
| CN103705856B (en) | For preventing the Chinese medicine composition of chemicotherapy acute radio-reaction | |
| CN103223143B (en) | Traditional Chinese medicine composition for treating simple obesity, and preparation method and application thereof | |
| CN109331129A (en) | A kind of Chinese medicine dietary product and preparation method thereof suitable for the proliferation of mammary gland | |
| CN103494939A (en) | Traditional Chinese medicine for treating senile habitual constipation | |
| CN103385953B (en) | A traditional Chinese medicine composition for the treatment of menopausal uterine fibroids and applications thereof | |
| CN103655940B (en) | A kind of Chinese medicine compound treating menopathy | |
| CN1290554C (en) | Medicine used for tonifying-kidney strengthening-yang and replenishing-qi to invigorate the spleen, and its prepn. method | |
| CN100571739C (en) | Herbal mixture of treatment cardiovascular disease and preparation method thereof | |
| CN105395777A (en) | A traditional Chinese medicine composition for treating yin-deficiency yang-hyperactivity type hypertension | |
| Chen et al. | Deciphering the anti-senescence immune paradigm: Kidney yin-yang equilibrium in traditional Chinese medicine | |
| CN113424956A (en) | Health-care product composition for preventing and treating gynecological lumps and preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| EXSB | Decision made by sipo to initiate substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180410 |